Hunt 'hopeful' of deal on Meningitis B vaccine price

The health secretary has said he is hopeful that a deal on a cost-effective price for a new Meningitis B vaccine can be reached with the manufacturers.

Jeremy Hunt said a change in the price the suppliers were asking for had changed "substantially" since the company which developed the vaccine was bought by GSK.